Cdk6’s functions are critically regulated by its unique C-terminus
Alessia Schirripa,
Helge Schöppe,
Sofie Nebenfuehr,
Markus Zojer,
Thorsten Klampfl,
Valentina Kugler,
Belinda S. Maw,
Huriye Ceylan,
Iris Z. Uras,
Lisa Scheiblecker,
Elisabeth Gamper,
Ulrich Stelzl,
Eduard Stefan,
Teresa Kaserer,
Veronika Sexl,
Karoline Kollmann
Affiliations
Alessia Schirripa
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Helge Schöppe
Institute of Pharmacy/Pharmaceutical Chemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria
Sofie Nebenfuehr
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Markus Zojer
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Thorsten Klampfl
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Valentina Kugler
Tyrolean Cancer Research Institute (TKFI), Innrain 66, 6020 Innsbruck, Austria; Institute of Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
Belinda S. Maw
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Huriye Ceylan
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Iris Z. Uras
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Lisa Scheiblecker
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Elisabeth Gamper
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
Ulrich Stelzl
Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria; Field of Excellence BioHealth - University of Graz, Graz, Austria
Eduard Stefan
Tyrolean Cancer Research Institute (TKFI), Innrain 66, 6020 Innsbruck, Austria; Institute of Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
Teresa Kaserer
Institute of Pharmacy/Pharmaceutical Chemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria
Veronika Sexl
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria; University of Innsbruck, Innsbruck, Austria
Karoline Kollmann
Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria; Corresponding author
Summary: The vital cell cycle machinery is tightly regulated and alterations of its central signaling hubs are a hallmark of cancer. The activity of CDK6 is controlled by interaction with several partners including cyclins and INK4 proteins, which have been shown to mainly bind to the amino-terminal lobe. We analyzed the impact of CDK6’s C-terminus on its functions in a leukemia model, revealing a central role in promoting proliferation. C-terminally truncated Cdk6 (Cdk6 ΔC) shows reduced nuclear translocation and therefore chromatin interaction and fails to enhance proliferation and disease progression. The combination of proteomic analysis and protein modeling highlights that Cdk6’s C-terminus is essential for protein flexibility and for its binding potential to cyclin D, p27Kip1 and INK4 proteins but not cyclin B. We demonstrate that the C-terminus is a unique and essential part of the CDK6 protein, regulating interaction partner binding and therefore CDK6’s functionality.